Short interest in NeuroSense Therapeutics Ltd (NASDAQ:NRSN) decreased during the last reporting period, falling from 570.76K to 487.26K. This put 1.74% of the company's publicly available shares short.

Based on the recent average volume of 135.26K shares traded per day, it would take 3.6 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.